This article was written by Follow Samuel Smith has a diverse background that includes being lead analyst and Vice President at several highly regarded...
This article was written by Follow Seeking Alpha’s transcripts team is responsible for the development of all of our transcript-related projects. We currently publish...
We previously covered XPeng (NYSE:XPEV) in October 2023, discussing the market’s over-reaction to its deliveries to Israel as conflict broke out in the area,...
Banner Corporation (NASDAQ:BANR) Q1 2024 Earnings Call Transcript April 18, 2024 11:00 AM ET Company Participants Mark Grescovich – President and CEORich Arnold –...
Overview AbbVie is a research-based biopharmaceutical company with immunology, oncology, aesthetics, and neuroscience expertise. In immunology, AbbVie is known for one of the most...
It’s been two weeks since my last article, and there have been some significant developments. On the macro side, “higher for longer” rate expectations...
Investment Overview – Arvinas’s Shares Buoyant As Vepdegestrant / Ibrance Combo Study Initiated I covered the “protein degradation” specialist drug developer Arvinas (NASDAQ:ARVN) in...